“ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE”. Asian Journal of Medical Research and Health Sciences 4, no. 2 (June 30, 2026): 1398–1403. Accessed July 1, 2026. https://www.ajmrhs.com/journal/article/view/617.